Chief Financial Officer
Dennis Mulroy joined AnaptysBio in July 2020. Prior to AnaptysBio, Mr. Mulroy has served as Chief Financial Officer of La Jolla Pharmaceutical Company, Taxus Cardium Pharmaceuticals Group, Molecular Imaging and SeraCare Life Sciences. Mr. Mulroy began his career as a Certified Public Accountant with Ernst & Young LLP after receiving his B.B.A. degree in accounting from the University of San Diego.